Personalized medicine test maker AssureRx Health completed an $11 million Series B round.
The Mason, Ohio-based company plans to use the funding to expand sales and marketing for its GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes. The company launched the test in 2009.
AssureRx also intends use the investment to develop an unspecified second product, according to the company.
AssureRx Health Inc., which sells a genetic test that helps doctors pick the right psychiatric drugs for patients based on their genes, has appointed a chief operating officer.
In addition to leading the personalized medicine developer’s operations, Donald Wright Jr. will manage product development, information technology and external relationships, according to the company.
Riding the personalized medicine wave, AssureRx Health Inc. has found a lead investor for a Series A investment round that it hopes reaches $10 million.
The Cincinnati-area company — which sells a genetic test that helps doctors pick the right psychiatric drugs for patients, based on their genes — has raised nearly $8 million in angel funding since it was launched five years ago, VentureWire reported.
By Mary Vanac
AssureRx Health Inc., the pharmacogenetic test maker in Mason, Ohio, raised $1.6 million in an equity offering from 22 investors.
MassDevice Network
@MassDevice
LinkedIn
YouTube